Search
for
Sort by
Research 91–120 of 227
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- The JAK/STAT signaling pathway: from bench to clinic
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Alopecia Areata: An Updated Review for 2023
- Mechanisms of autophagy and their implications in dermatological disorders
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- 496 Understanding the mechanism of action of secukinumab using lesional hidradenitis suppurativa skin organ culture
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Alopecia Areata: Current Treatments and New Directions
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Application of Baricitinib in Dermatology
- Alopecia areata – Current understanding and management